Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    The AAV Vector Challenge With Selecta's Dr. Carsten Brunn

    The AAV Vector Challenge With Selecta's Dr. Carsten Brunn

    FromBusiness Of Biotech

    Start listeningView podcast show

    The AAV Vector Challenge With Selecta's Dr. Carsten Brunn

    FromBusiness Of Biotech

    ratings:
    Length:
    32 minutes
    Released:
    Jan 11, 2021
    Format:
    Podcast episode

    Description

    The Business of Biotech kicks off our Cell & Gene Miniseries with Dr. Carsten Brunn, President & CEO at Selecta Biosciences. Guest host Erin Harris, chief editor at cellandgene.com, joins us for a discussion on Selecta's ImmTOR platform and how the company is addressing the immunogenicity of adeno-associated virus (AAV) vectors challenge faced by gene therapy companies.
    Released:
    Jan 11, 2021
    Format:
    Podcast episode

    Titles in the series (100)

    The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.